康臣药业(01681)10月22日斥资433.08万港元回购28.3万股

Core Viewpoint - 康臣药业 announced a share buyback plan, indicating confidence in its stock value and potential for future growth [1] Group 1: Company Actions - 康臣药业 plans to repurchase 283,000 shares at a total cost of HKD 4.3308 million [1]